Molagri raises $5.8M for 'updatable' biopesticides that adapt to resistance
What's the deal? Toronto-based MolagriDealroom has a profile for this one. Try Dealroom → has raised $5.8 million in seed funding to build "precision biopesticides" designed to target specific insect pests and adapt as those pests develop resistance. Convective CapitalDealroom has a profile for this one. Try Dealroom → led the round, with SuperorganismDealroom has a profile for this one. Try Dealroom →, Y Combinator, Julian CapitalDealroom has a profile for this one. Try Dealroom →, and angel investors including Y Combinator cofounder Paul GrahamDealroom has a profile for this one. Try Dealroom → participating.
What's the endgame? Molagri's platform uses engineered, non-infectious virus-like particles (VLPs) ingested by target pests. Surface proteins bind to receptors in the insect's gut, then deliver mRNA instructions that make the pest produce a toxin that kills it; beneficial insects like pollinators lack the receptor, so they're unaffected.
Why updatable? The platform is modular. Instead of building a new pesticide each time an insect evolves resistance, Molagri aims to keep the delivery system and swap out the targeting protein or the toxic payload.
Cofounder Zaky Hassan frames it in medical terms. "Farmers shouldn't have to worry about resistance, the same way you don't think about which flu strain is going around when you get a flu shot," he said. "We want to be the team that designs the next product before resistance becomes a problem in the field."
Where it's starting: Molagri will first target pests in tree nuts and tree fruits. The founders, Hassan and Min Jin, are drawing on backgrounds in structural biology and protein engineering, and have already used cryogenic electron microscopy to map a honeybee receptor — a step toward designing proteins that bind to pests but not pollinators.
What could go wrong? The company hasn't yet shown this selectivity in commercial field conditions. The business model also hinges on regulators: if every updated version requires a full pesticide registration, much of the speed advantage disappears. Molagri hopes regulators will review platform modifications without treating each as an entirely new product.
The signal: At $5.8 million, Molagri's seed round sits in the 95th percentile of all-time seed rounds for Canadian food startups, a sample of 403 deals. That scale of early backing points to investor appetite for crop-protection tools that promise precision over the broad-spectrum products dominating the market.
Read more: agfundernews.com
Image credit: Molagri
